Newsroom

Sorted by: Latest

-

AM Green nominata vincitrice del lotto asiatico all'asta di H2Global finanziata dal governo tedesco

AMBURGO, Germania e HYDERABAD, India--(BUSINESS WIRE)--AM Green Ammonia (India) Private Limited ("AM Green") è stata scelta come unico vincitore del lotto asiatico all'asta di H2Global condotta da HINT.CO GmbH ("Hintco"), aggiudicandosi un accordo di acquisto a lungo termine per la fornitura alla Germania di ammoniaca RFNBO (Renewable Fuels of Non-Biological Origin, Combustibili rinnovabili di origine non biologica). L'appalto è stato assegnato a seguito di una procedura di gara in cui l'offert...
-

AM Green ganó la licitación para Asia de la subasta H2Global financiada por el Gobierno alemán

HAMBURGO, Alemania; y HYDERABAD, India--(BUSINESS WIRE)--AM Green Ammonia (India) Private Limited ("AM Green") ha sido seleccionada como única ganadora de la licitación para Asia de la subasta H2Global, gestionada por HINT.CO GmbH ("Hintco"). Esto le permite asegurar un acuerdo de compra a largo plazo para el suministro de amoníaco clasificado como combustible renovable de origen no biológico (RFNBO) a Alemania. La adjudicación se produce tras un proceso de licitación competitivo en el que la o...
-

AM Green wint Aziatische kavel in H2Global-veiling, gefinancierd door Duitse overheid

HAMBURG, Duitsland & HYDERABAD, India--(BUSINESS WIRE)--AM Green Ammonia (India) Private Limited ('AM Green') is geselecteerd als enige winnaar van de Aziatische kavel in de H2Global-veiling, georganiseerd door HINT.CO GmbH ('Hintco'), waarmee een langetermijncontract is veiliggesteld voor de levering van ammoniak – geclassificeerd als hernieuwbare brandstof van niet-biologische oorsprong (RFNBO) – aan Duitsland. De toewijzing volgt op een competitief biedproces waarbij het bod van AM Green als...
-

AM Green remporte le lot asiatique de l'appel d'offres H2Global financé par le gouvernement allemand

HAMBOURG, Allemagne et HYDERABAD, Inde--(BUSINESS WIRE)--AM Green Ammonia (India) Private Limited (« AM Green ») a été désignée unique lauréate du lot asiatique dans le cadre de l'appel d'offres H2Global organisé par HINT.CO GmbH (« Hintco »). Elle décroche ainsi un contrat d'achat à long terme pour fournir à l'Allemagne de l'ammoniac classé comme carburant renouvelable d'origine non biologique (RFNBO). Cette attribution fait suite à un processus de mise en concurrence au cours duquel l'offre d...
-

AM Green wurde zum Gewinner des asiatischen Loses bei der von der deutschen Regierung finanzierten H2Global-Auktion ernannt

HAMBURG, Deutschland & HYDERABAD, Indien--(BUSINESS WIRE)--AM Green Ammonia (India) Private Limited („AM Green“) wurde als alleiniger Gewinner des asiatischen Loses im Rahmen der von der HINT.CO GmbH („Hintco“) durchgeführten H2Global-Auktion ausgewählt und sicherte sich damit einen langfristigen Abnahmevertrag über die Lieferung von Ammoniak aus erneuerbaren Brennstoffen nicht-biologischen Ursprungs (RFNBO) nach Deutschland. Die Vergabe erfolgte im Anschluss an ein Ausschreibungsverfahren, bei...
-

Accenture Reports Fourth-Quarter and Full-Year Fiscal 2026 Results

NEW YORK--(BUSINESS WIRE)--Accenture reported financial results for the fourth quarter and full fiscal year ended August 31, 2026....
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

NICE issues final draft guidance recommending ▼ Tryngolza® (olezarsen) as an option to treat genetically confirmed familial chylomicronaemia syndrome (FCS) in adults in England and Wales

CAMBRIDGE, England--(BUSINESS WIRE)--FOR UK HEALTHCARE/TRADE MEDIA ONLY Sobi® UK today announced that the National Institute for Health and Care Excellence (NICE) has issued final draft guidance which recommends Tryngolza® (olezarsen) as an option to treat genetically confirmed familial chylomicronaemia syndrome (FCS) in adults in England and Wales, only if response to diet and conventional triglyceride-lowering treatments (such as statins and fibrates) has been inadequate. FCS is an ultra-rare...
-

Integrated Dermatology Promotes Nicholas Anguish to Chief Executive Officer

BOCA RATON, Fla.--(BUSINESS WIRE)--Integrated Dermatology names President Nicholas Anguish CEO, effective October 1, 2026. He succeeds Tushar Ramani, MD, who remains on the board....
-

Qnity Schedules Third Quarter 2026 Earnings Release and Conference Call

WILMINGTON, Del.--(BUSINESS WIRE)--Qnity Electronics, Inc. (“Qnity”) (NYSE: Q), will release its third quarter 2026 financial results before the opening of the market on Wednesday, November 4, 2026. In addition, the company will host a conference call at 8:00 a.m. ET that day. Investors can join the conference call via telephone by dialing (800) 343-5172 (domestic) or +1 (203) 518-9856 (international) and using the participant code QNITY. An audio-only live webcast and presentation materials, a...